1 page based on IMPLICATIONS/CONCLUSION based on how Tegaderm CHG IV securement dressing for central venous and arterial catheter insertion sites to inhibit growth of microorganisms involved in central-line associated bloodstream infections, verses the standard IV dressings. What do these findings mean for clinical practice? These findings can be things such as lowers catheter related infections, decreasing hospital stay, readily adopted into clinical practice, saves on cost, etc,. No cover page needed, as this is just a portion of the paper. I have one reference I will attached to use, and any other references used is okay as well.
